Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02048280 · ClinicalTrials.gov registry record · NA
Comparing NAVA Levels in Intubated and Recently Extubated Neonates to Determine Optimal Non-invasive Ventilatory Support
A NA study of Other Specified Respiratory Problems in Fetus or Neonate, sponsored by ProMedica Health System.
- Completed
- Registry status
- NA
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT02048280: Completed NA study of Other Specified Respiratory Problems in Fetus or Neonate, sponsored by ProMedica Health System.
NCT02048280 is a NA study of Other Specified Respiratory Problems in Fetus or Neonate that has completed, run by ProMedica Health System. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02048280, a NA study of Other Specified Respiratory Problems in Fetus or Neonate, has completed, sponsored by ProMedica Health System.
- COMPLETED
- Registry status
- NA
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
Neurally adjusted ventilatory assist (NAVA) is a mode of mechanical ventilation that uses the diaphragm's normal electrical activity to deliver a mechanically supported breath. The amount of support provided is determined in part by the NAVA level, where a higher NAVA level will provide higher level of support and unload more of the work of the diaphragm. The purpose of this study is to compare the optimal NAVA level in neonates while on mechanical ventilation while intubated and after being extubated.
Primary Outcome
NAVA titration study will be done pre and post extubation to determine and then compare the breakpoint.
Conditions Studied
Interventions
- PROCEDURE NAVA level
- OTHER NAVA level
Study Locations (1)
Ohio
- Promedica Toledo CHildren's Hospital NICU - Toledo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2012-12 |
| Est. Completion | 2015-04 |
| Phase | NA |
What the finished NCT02048280 record still lists
NCT02048280 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 1 condition, with Other Specified Respiratory Problems in Fetus or Neonate appearing as the primary indexed condition, and to 2 interventions - of which NAVA level is the first listed.
NCT02048280 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT02048280 about?
NCT02048280 is a clinical study titled "Comparing NAVA Levels in Intubated and Recently Extubated Neonates to Determine Optimal Non-invasive Ventilatory Support". Neurally adjusted ventilatory assist (NAVA) is a mode of mechanical ventilation that uses the diaphragm's normal electrical activity to deliver a mechanically supported breath. The amount of support provided is determined in part by the NAVA level, where a higher NAVA level will provide higher level...
What is the current status of trial NCT02048280?
This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2012-12. Estimated completion is 2015-04.
What conditions does trial NCT02048280 study?
This clinical trial studies the following conditions: Other Specified Respiratory Problems in Fetus or Neonate.
What interventions are being tested in trial NCT02048280?
The interventions under investigation include: NAVA level (PROCEDURE), NAVA level (OTHER).
Who is sponsoring clinical trial NCT02048280?
This trial is sponsored by ProMedica Health System, which has 12 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02048280 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02048280's enrollment target sits among peer trials
15 1881st of 2000 higher than 92 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia